1. Introduction {#s0005}
===============

Nowadays, magnetic resonance imaging (MRI) is used to non-invasively investigate tissue loss overtime ([@bb0035], [@bb0165], [@bb0250], [@bb0310], [@bb0330]), whereas in the early days it was predominantly investigated through post-mortem studies ([@bb0015], [@bb0060], [@bb0055], [@bb0120]). Therefore, brain tissue loss can be assessed prior to death and changes can be monitored during life ([@bb0100], [@bb0170], [@bb0175], [@bb0165], [@bb0180]). Characterization of chronic brain atrophy by means of MRI is already well established and used widely in longitudinal studies ([@bb0165], [@bb0310]). The current brain imaging techniques and analysis tools are, however, so sensitive and precise that changes in brain volume can be measure up to around 0.5% ([@bb0085], [@bb0095], [@bb0310], [@bb0325]). These changes lie within the range of yearly brain changes in normal aging ([@bb0150]) and may be short-term physiological fluctuations of the brain caused by fluid restriction ([@bb0050], [@bb0125], [@bb0130], [@bb0245], [@bb0240], [@bb0265], [@bb0340]) or use of medication, but could also be caused by pathological processes like diabetes, hypertension and Alzheimer\'s disease (AD) ([@bb0260], [@bb0345]). In addition, it is though that during the night a redistribution of body fluids occurs, therefore brain volume even changes during the day, with a decrease in volume observed by the end of the day ([@bb0285]). For an accurate interpretation of brain volume measurements it is, therefore, essential to know to what extent the short-term changes -- ranging from hours to a couple of days -- are caused by physiological fluctuations or due to pathological differences. Furthermore for the interpretation of longitudinal data knowledge of the short-term changes is also crucial since they may introduce bias and additional corrections may be needed. Therefore, in this review, we discuss the possible mechanisms that can influence global brain volumes on a short-time basis. We first focus on the MRI sequences used to image brain changes, then we shift focus to the analysis tools and finally we elaborate on the different mechanisms influencing volumetric brain dynamics.

2. Magnetic resonance imaging and analysis tools {#s0010}
================================================

MRI allows for the detection of both structural and functional changes. For the short-term changes the used techniques are: 3D T~1~- and T2-weighted imaging, ^1^H-MR spectroscopy, blood‑oxygenated level dependent functional MRI (BOLD-fMRI), and pseudo-continuous arterial spin labeling (pcASL). 3D T1-and T~2~-weighted imaging is used to measure structural brain changes, like atrophy. ^1^H-MR Spectroscopy determines the magnetic properties of ^1^H atoms. BOLD-fMRI enables the indirect measure of differences in neural activity of the resting-state and pcASL provides information about the perfusion status of the brain and permits quantification of cerebral blood flow perfusion, thus measuring blood flow alterations and perfusion deficits in various disorders ([@bb0010]).

Many analysis tools exist to analyze the above-mentioned imaging techniques. Analysis libraries commonly used for this are FMRIB\'s software library (FSL) ([@bb0230], [@bb0335], [@bb0360]) and statistical parameter mapping (SPM) ([@bb0030]). The libraries contain of different analysis tools, either to analyze functional imaging data obtained from fMRI or to analyze anatomical data from the 3D T1-weighted images. Combining the tools available in the libraries allow for robust measurements. When focusing on normal aging, atrophy rates are shown to lie between 0.1 and 0.3% per year ([@bb0150], [@bb0160], [@bb0305]). For the neurodegenerative disorders, atrophy rates are higher, with annual rates between 1.0 and 3.0% ([@bb0165], [@bb0225]). As such, these analysis tools have led to increased knowledge about annual atrophy rates in normal aging and neurodegenerative disorders, but can also be used so assess the short-term changes and their role in longitudinal studies.

3. Short-term mechanisms {#s0015}
========================

Now we shift focus towards the short-term mechanisms of brain volume changes. As mentioned, these changes may be physiological fluctuations of the brain, but can also be caused by pathological processes. Furthermore short-term mechanisms may influence different regions of the brain, depending on the mechanism but also on the method used to analyze changes. Regions to be affected are: gray and white matter, total brain, subcortical regions and ventricles. Moreover the overall BOLD response and perfusion may be affected as well. Short-term changes are defined as changes caused within hours to a couple of days, depending on the investigated mechanism. In the sections below we will discuss each of these mechanisms in more detail.

3.1. Hydration status {#s0020}
---------------------

### 3.1.1. Fluid restriction {#s0025}

Since the introduction of automated analysis tools many studies have been conducted to investigate annual atrophy rates in several neurodegenerative disorders. Moreover, with the use of these tools evaluation on therapy can be monitored. There are, however, factors that influence brain volume on a physiological level. Therefore corrections are needed to overcome potential overshadowing or overestimation of treatment effect or over- or underestimations of the annual atrophy rates in longitudinal studies by these fluctuations. One mechanism influencing brain volume is the hydration status of the brain. A couple of studies investigated the effect of dehydration on brain volume ([@bb0050], [@bb0130], [@bb0265], [@bb0280], [@bb0340]). These studies relatively consistently showed that brain volume is affected by fluid restriction for 9 ([@bb0265]), 12 ([@bb0050]), or 16 ([@bb0130]) hours or longer ([@bb0340]), with a decrease in brain volume ranging from − 0.03% ([@bb0265]) to − 1.7% ([@bb0340]) when examining structural 3D T~1~-weighted MRI scans ([Table 1](#t0005){ref-type="table"}). However, the study from [@bb0280] did not find any differences during the dehydration state. But baseline scans, indicating normal hydration, were obtained several days or even weeks before the dehydration scan resulting in a less-controlled research set-up, which may have contributed to these negative results. Moreover, the observed decrease in brain volume nicely corresponded to an increase in cerebrospinal fluid (CSF) volume between 0.22% and 2.6% as was demonstrated by [@bb0265] and [@bb0340], respectively. Focusing on the effects of rehydration, also consistent results have been shown ([@bb0050], [@bb0130], [@bb0265], [@bb0280], [@bb0340]), demonstrating increased brain volumes after rehydration with a range between 0.15% ([@bb0265]) and 3.5% ([@bb0340]) with a corresponding decrease in CSF volume ([@bb0265]) ([Table 1](#t0005){ref-type="table"}). Additional, ^1^H--MR Spectroscopy also demonstrated a decrease and an increase of brain tissue fluid after dehydration and rehydration, respectively ([@bb0050]).Table 1Studies investigating mechanisms of brain volume fluctuations.Table 1MechanismAuthorMRI sequenceAnalysis tool (version)Study populationNumber of patientsEffect on brain volume\
(numbers in %)Effect on ventricular volumeDehydration-*Fluid restriction*[@bb0130]-3D T1-weightedSIENA (FSL)Healthy volunteers20↓ 0.55[⁎⁎](#tf0010){ref-type="table-fn"}--↑ 0.72[⁎](#tf0005){ref-type="table-fn"}n.a[@bb0340]-3D T1-weightedVBM8 (SPM), SIENAr (v5.0) and FreeSurfer (v4.5)Healthy volunteers6↓ 1.7[⁎⁎](#tf0010){ref-type="table-fn"}--↑ 3.5[⁎](#tf0005){ref-type="table-fn"}↑ 2.6[⁎⁎](#tf0010){ref-type="table-fn"}[@bb0280]-3D T1-weighted\
-2D dual echo T2-weighted (for T2-relaxation)BET, SIENAX & Jacobian integration method (all FSL v5.0)Healthy volunteers14No effect of dehydration -↑ 0.36[⁎](#tf0005){ref-type="table-fn"}n.a[@bb0050]-3D T1-weightedFreeSurfer (v5.3.0)Healthy volunteers15↓ 0.36[⁎⁎](#tf0010){ref-type="table-fn"}--↑ 0.87[⁎](#tf0005){ref-type="table-fn"}n.a-FLASH (T1-relaxation)--No effectn.a.-^1^H-MR Spectroscopy (brain tissue fluid H~2~O)LCModel↓ 1.63[⁎⁎](#tf0010){ref-type="table-fn"}--↑ 0.43[⁎](#tf0005){ref-type="table-fn"}[@bb0265]-3D T1-weightedFLIRT, FAST, BET (all FSL v5.0) and ALVIN (v1.06)Healthy volunteers20↓ 0.03 (ns)[⁎⁎](#tf0010){ref-type="table-fn"}--↑ 0.15 (ns)[⁎](#tf0005){ref-type="table-fn"}↑ 0.22 (ns)[⁎⁎](#tf0010){ref-type="table-fn"}--↓ 0.62 (ns)[⁎](#tf0005){ref-type="table-fn"}-T2 relaxationDehydration-*Exercise*[@bb0125]-3D T1-weightedAnalyze (v7.0)Trained healthy volunteers6No effectNo effect[@bb0240]-3D T1-weightedSIENA (v2.4), MEASURETrained healthy volunteers7No effect↑(No percentages mentioned)[⁎⁎](#tf0010){ref-type="table-fn"}[@bb0245]-3D T1-weightedSPM5Healthy volunteers10No effect↑(No percentages mentioned)[⁎⁎](#tf0010){ref-type="table-fn"}-BOLD-fMRI↑ BOLD responsen.a-pcASL↑ Blood flown.aDiurnal fluctuations[@bb0285]-3D T1-weightedBEaST (v1.15) and FAST (FSL v5.0)MS and AD1589↓ 0.180--0.438n.a[^1][^2][^3]

### 3.1.2. Exercise {#s0030}

Different from the dehydration studies examining the effects of fluid restriction, studies focusing on dehydration as caused by thermal-exercise ([@bb0125], [@bb0245], [@bb0240]) did not find any differences in brain volume. Three layers of clothing created the thermal exercise condition. After extensive exercise the brain volumes were comparable to the volumes before exercise. However, two studies have found increased volumes of CSF after a thermal-exercise dehydration challenge ([@bb0245], [@bb0240]), which is comparable to the effect of fluid restriction ([Table 1](#t0005){ref-type="table"}). One of these studies ([@bb0245]) also investigated the effect of thermal-exercise on the blood oxygenation level dependent (BOLD) response and on cerebral blood flow by means of pcASL. They showed that both the BOLD response and the cerebral blood flow go up after thermal-exercise for 90 min ([Table 1](#t0005){ref-type="table"}). Taken together, it seems that exercise induces a different kind of dehydration status in the brain as compared with fluid restriction, but the exact difference need to be elucidated.

3.2. Diurnal fluctuations {#s0035}
-------------------------

A recent study has demonstrated that brain volume also fluctuates during the day ([@bb0285]). Investigating both AD (ADNI trial) and MS (RESTORE ([@bb0175]) and DEFINE ([@bb0195]) trials) patients they have showed that brain volumes are larger in the morning, and decrease during the day ([@bb0285]). They demonstrated a reduction of − 0.180% in the MS group and a reduction of even − 0.442% in the AD group when comparing morning brain volumes with evening brain volumes ([Table 1](#t0005){ref-type="table"}). Since annual atrophy rates lie between − 0.253% in MS and − 0.913% in elderly people ([@bb0285]), it is not assumed to be an irreversible effect and this difference must be accompanied with a similar increase during the night. However, this feels somewhat counterintuitive since brain volume tends to decrease after dehydration and the fluid intake is often smaller during nighttime. The authors hypothesized that redistribution of body fluid may be the possible mechanism involved in the increase in brain volume after sleep. Other mechanisms may be the effect of daily medication intake, which most often takes place during the morning and after lunch and may be diurnal. Also, cortisol levels fluctuate during the day and are higher in the morning ([@bb0190]), possible affecting brain volumes during the day.

3.3. Medication, surgery, and pathological processes {#s0040}
----------------------------------------------------

As where the percentages change in brain volume are given for dehydration and day-to-night fluctuation studies, the percentages are relatively sparse for the effect of medication, surgery and pathological processes on global brain volume. Therefore, in this section, we will speculate on the potential mechanisms that may influence brain volume on a short-term (hours to days), but sometimes also on a long-term (approximately one year) basis, where we focus on anti-inflammatory drugs, antipsychotics, surgical revascularization, hypertension, diabetes mellitus and AD. Moreover, here we will also address the regional brain volume changes as caused by the above-mentioned mechanisms.

### 3.3.1. Medication -- anti-inflammatory drugs {#s0045}

Water-related brain volume fluctuations are also believed to occur in inflammatory brain edema ([@bb0375]). It was shown that in MS patients, atrophy rates were accelerated during the first years of treatment with anti-inflammatory drugs like Natulizumab ([@bb0270], [@bb0310]), but disappeared during the second year. As such it is suggested that a so-called "pseudoatrophy" phenomenon exists where the observed reduction in brain volume is not the consequence of atrophy and cellular loss itself but rather caused by water shifts. A study ([@bb0310]) investigating this phenomenon in more detail in MS patients demonstrated that the volumetric brain changes were mainly driven by white matter ([@bb0155]), indicating that the inflammatory white matter lesions may be related to these changes. As a result pseudoatrophy may lead to an overshadowing of the real treatment effect and makes it complicated to assess the effect of true brain atrophy if not taken into account.

### 3.3.2. Medication -- corticosteroids {#s0050}

Corticosteroids are drugs given for a variety of diseases, and have an anti-inflammatory and immunosuppressive action. Therefore, many side effects are observed for this type of medication. Focusing on brain volumetric effects two different regions are found to be affected: the hippocampus and the amygdala, both playing a role in short-term memory processing. The first study investigating the effect of chronic corticosteroid exposure (year) on hippocampal volume demonstrated a volumetric decrease of 8% on the left and 9% on the right as compared to healthy volunteers ([@bb0065]). This study was however retrospective. Later, prospective, studies demonstrated volume differences ranging from no effect at all ([@bb0105], [@bb0205]) to inconsistent results (11% decrease on the left, and 4% increase on the right) ([@bb0070]) to a mean decrease of 1.69% ([@bb0080]). Besides hippocampal volume differences, differences in amygdala volume are observed ([@bb0075]), with a decrease of 20% on the left side and 11% on the right. Although most studies investigated chronic corticosteroid exposure, brain volume changes have been observe and should be accounted for in the interpretation of longitudinal studies.

### 3.3.3. Medication -- antipsychotics {#s0055}

Antipsychotic drugs can be classified into typical (first generation antipsychotics) and atypical (second generation antipsychotics) antipsychotics. A recent meta-analysis comparing the typical to the atypical revealed differences in gray matter volume loss between the two groups ([@bb0350]). The latter group was associated with less progressive gray matter loss with higher mean daily medication intake as compared to the first group ([@bb0350]). Therefore, this part will be subdivided into the effects of typical and the atypical classes on brain volumes. Since there are many studies that have investigated this issue and a thorough review on this topic is not the focus of this review, we will only focus on the most recent studies. First, for the typical drugs an increase in basal ganglia volume ([@bb0135], [@bb0235], [@bb0320]) and lateral ventricles ([@bb0235]) has been observed. Smaller total brain volumes and hippocampal volumes accompany the increase in ventricle volume ([@bb0235]). Second, the atypical drugs are associated with both reductions ([@bb0005], [@bb0235], [@bb0315], [@bb0210]) in volume as with increases in volume ([@bb0200], [@bb0235], [@bb0370]) and thus very inconclusive. Some studies combine both typical and atypical antipsychotics ([@bb0025], [@bb0185], [@bb0220], [@bb0290]) and effects are again inconsistent. For more details and the chronic impact of antipsychotic drugs in general read the recent review of [@bb0020]. Most of the studies discussed are longitudinal studies, they do, however, show that the progression of brain volume loss already starts relatively early after the start with antipsychotics. As such, antipsychotic medication intake should be collected in longitudinal studies.

### 3.3.4. Surgical revascularization {#s0060}

Chronic regional blood flow impairments can lead to thinning of the cortex, without global tissue loss ([@bb0140]). Brain perfusion may be sufficient enough to prevent from ischemia in these cases, but when neuronal activity increases it fails ([@bb0145]). The cerebrovascular reactivity (CVR) -- the cerebral blood flow in response to a vasodilatory or vasoconstrictive stimulus --, can be used to assess the integrity of blood flow and CVR reductions are found to range between blunted increases in blood flow to a phenomenon called steal where blood flow is taken from the region with reduced cerebral blood flow in patients with severe steno-occlusive disease ([@bb0145]). Hence, it was hypothesized that the reduction in vascular reserve is associated with cortical thinning ([@bb0145]). [@bb0145] studied patients presented with steno-occlusive disease and the steal phenomenon. They demonstrated that restoring the CVR by means of surgical revascularization, resulted in a 5.1% increase in mean cortical thickness in the revascularized hemisphere.

### 3.3.5. Pathological conditions {#s0065}

In a recent review the authors discussed the potential bias of atrophy rates caused by type 2 diabetes mellitus or hypertension ([@bb0260]). Diabetes can alter brain function and structure probably on two levels. First, insulin transport across the blood brain barrier is reduced in patients with type 2 diabetes ([@bb0215]). Consequently, the resulting low levels of brain insulin directly affect the cognitive state of the patient, especially in the medial temporal lobe where insulin receptors are abundant ([@bb0110], [@bb0115]). Moreover, an indirect pathway leads to increased levels in amyloid beta and tau caused by down-regulation of insulin degrading enzyme ([@bb0255]). This enzyme plays a role in the degradation of amyloid and as a result aggregation of amyloid takes place ([@bb0090]), which is one of the hallmarks of AD and essential in neurodegeneration ([@bb0055]). Second, hyperglycemia can cause macro-and microvascular damage. Additional, type 2 diabetes may decrease blood flow velocities, increase cerebrovascular resistance and impair vasoreactivity ([@bb0295]). These changes may ultimately lead to brain volume changes and altered function ([@bb0260]). This is in line with studies demonstrating modest brain volume loss in diabetes ([@bb0045], [@bb0355]). As for hypertension, cerebral circulation is stressed by the increase in blood pressure ([@bb0300]). As a consequence there will be thickening of the vessel wall and an increased vascular resistance, mainly in the smaller blood vessels ([@bb0260]). This increase in vascular resistance leads to blood flow reduction and has been linked to cognitive impairment ([@bb0260]) and brain volume decreases ([@bb0040], [@bb0275]). Since both diabetes and hypertension, but also AD, affect brain volume, it is tempting to suggest that a common pathological process exists between these disease entities. [@bb0345] suggested hypohydration to be a mechanism possibly involved in the development of these diseases. Linking this hypothesis to the effects of hydration status on brain volume, there might indeed be a potential role of dehydration as a mechanism for the diseases. In that case AD, diabetes and hypertension may reflect a chronically dehydrated status, resulting in decreased brain volumes ([@bb0345]).

4. Discussion and future directions {#s0070}
===================================

Many short-term mechanisms do have an effect on brain volume. For the interpretation of longitudinal data the effect of short-term mechanisms should not be underestimated. The percentage brain volume change during the day is in the same order of magnitude as yearly atrophy rates in normal aging ([@bb0150]). As such longitudinal brain volume measurements may include effects from short-term physiological mechanisms, confounding the measurements and interpretation of longitudinal studies. Especially studies that assess therapy response or deterioration in brain volume may be impacted and biased by the effect of short-term physiological changes. One example of bias created by short-term mechanisms is the diurnal fluctuations in brain volume, creating bias in longitudinal data when scanning is not aligned. Thus the moment of scanning for every longitudinal point should be approximately the same for a single volunteer. The other mechanisms, medication, hypertension, diabetes, and (de)hydration, should be collected and adjusted for in longitudinal studies to overcome bias created by these mechanisms.

Taking the effects of (de)hydration, day-to-night fluctuations, medication and pathological processes like hypertension and diabetes together, it would be interested to investigate the role of these different mechanisms on the healthy aging brain and the brain of demented patients. In that way we might be able to assess whether different mechanisms may influence brain volume in different ways when comparing healthy elderly people to demented patients. For the hydration status it may be hypothesized that rehydration may be more affective in healthy aging, because when AD is already present the chronic dehydration status may overrule the effect of rehydration on brain volume, resulting in a decrease in volume increase after rehydration. When comparing diurnal fluctuations, it might be that different volume effects exist. The healthy brain may possibly have a better ability to regulate its volume during the day, therefore it may be hypothesized that brain volume changes over the day may be smaller ([@bb0345]). Third, as we know hypertension to decrease brain volume, it would be interesting to what other effects hypertension has on brain and CSF volume, like diurnal fluctuations or medication effects. It may be suggested that similar to AD and MS, diurnal fluctuations exist. Hence it can be hypothesized that in de morning brain and CSF volume is greater as compared to the evening. The decrease by the end of the day in CSF volume may be a result of glymphatic activity during the night, where the interstitial fluid increased by approximately 60% to clear the brain from toxins and metabolites ([@bb0365]). Similar to the medication studies, the other factors influencing brain volume should also be investigated on a regional level. This will uncover differences in tissue type (white matter, gray matter, basal ganglia) and may show differences in specific areas rather than whole brain alone. Fourth, age-related differences may exist with regard to brain volume and the effect of short-term mechanisms. Since younger, developing, brains are more prone to disturbances it may be that for instance medication has a greater effect on brain volume in children and adolescents as it has in adults. Yet, to our knowledge, these studies have not been conducted but would be of great value to understand the role of short-term changes in the developing brain and whether these changes may reversible or not.

5. Conclusion {#s0080}
=============

Taken together, with the use of MRI and different analysis tools it is shown that multiple mechanisms influence volumetric brain dynamics. These mechanisms may increase, decrease or have no effect on brain volume ([Fig. 1](#f0005){ref-type="fig"}). But all may influence an accurate interpretation of longitudinal brain volume measurements. In the upcoming years, attention should be directed towards studies investigating physiological short-term changes within the light of long-term chronic pathological changes. Ultimately this may lead to a better understanding of the physiological short-term effects of pathological processes and may aid in early detection of brain vulnerability or resilience to atrophy.Fig. 1Mechanisms influencing volumetric brain dynamics. Several mechanisms may influence brain volume on a short-term, or long-term basis. Mechanisms with a negative influence on global brain volume, thus decreasing it, are: fluid restriction, evening MRI measurements, corticosteroids, antipsychotics and pathological processes such as Alzheimer\'s disease, hypertension and diabetes mellitus type 2. Mechanisms with a positive influence, thereby increasing brain volume are: fluid intake, morning MRI measurements, surgical revascularization and probably medications like anti-inflammatory drugs and anti-hypertensive medication. Exercise does not seem to have any effect on brain volume.Fig. 1.

6. Search strategy and selection criteria {#s0085}
=========================================

References for this Review were identified through a search of PubMed between March 1968 and June 2016, and references from relevant articles. A snowball search using [@bb0285] as reference paper was used to select these relevant papers. In addition, the search terms "brain volume MRI", "brain volume dehydration", "brain volume anti-inflammatory", and "magnetic resonance imaging" were used. Again, a snowball search was used to identify additional papers relevant to this topic. Only papers in English were reviewed and had to be restricted to the human brain. The final reference list was generated on the basis of relevance to the topics covered in this Review.

[^1]: *n*.*a*. = *not applicable*.

[^2]: *after rehydration*.

[^3]: *after dehydration*.
